Abstract

BackgroundThis study evaluated whether there is a relationship between the zona pellucida birefringence (ZP-BF) intensity and the nuclear (NM) and cytoplasmic (CM) in vitro maturation of human oocytes from stimulated cycles.ResultsThe ZP-BF was evaluated under an inverted microscope with a polarizing optical system and was scored as high/positive (when the ZP image presented a uniform and intense birefringence) or low/negative (when the image presented moderate and heterogeneous birefringence). CM was analyzed by evaluating the distribution of cortical granules (CGs) throughout the ooplasm by immunofluorescence staining. CM was classified as: complete, when CG was localized in the periphery; incomplete, when oocytes presented a cluster of CGs in the center; or in transition, when oocytes had both in clusters throughout cytoplasm and distributed in a layer in the cytoplasm periphery Nuclear maturation: From a total of 83 germinal vesicle (GV) stage oocytes, 58 of oocytes (69.9%) reached NM at the metaphase II stage. From these 58 oocytes matured in vitro, the high/positively scoring ZP-BF was presented in 82.7% of oocytes at the GV stage, in 75.8% of oocytes when at the metaphase I, and in 82.7% when oocytes reached MII. No relationship was observed between NM and ZP-BF positive/negative scores (P = 0.55). These variables had a low Pearson's correlation coefficient (r = 0.081). Cytoplasmic maturation: A total of 85 in vitro-matured MII oocytes were fixed for CM evaluation. Forty-nine oocytes of them (57.6%) showed the complete CM, 30 (61.2%) presented a high/positively scoring ZP-BF and 19 (38.8%) had a low/negatively scoring ZP-BF. From 36 oocytes (42.3%) with incomplete CM, 18 (50%) presented a high/positively scoring ZPBF and 18 (50%) had a low/negatively scoring ZP-BF. No relationship was observed between CM and ZP-BF positive/negative scores (P = 0.42). These variables had a low Pearson's correlation coefficient (r = 0.11).ConclusionsThe current study demonstrated an absence of relationship between ZP-BF high/positive or low/negative score and nuclear and cytoplasmic in vitro maturation of oocytes from stimulation cycles.

Highlights

  • This study evaluated whether there is a relationship between the zona pellucida birefringence (ZP-BF) intensity and the nuclear (NM) and cytoplasmic (CM) in vitro maturation of human oocytes from stimulated cycles

  • Oocyte retrieval was performed after 36 hours of rhCG administration by transvaginal ultrasound-guided aspiration. Participants This prospective study was conducted on 92 patients who were admitted to an intracytoplasmic sperm injection (ICSI) program at the Center for Human Reproduction Prof

  • Nuclear maturation From a total of 83 germinal vesicle (GV) oocytes, 58 oocytes (69.9%) reached nuclear maturation (NM) (MII stage). From these 58 oocytes matured in vitro, a high/positively scoring ZP birefringence (ZP-BF) was presented in 82.7% of GV oocytes, 75.8% of MI oocytes, and 82.7% of MII oocytes

Read more

Summary

Introduction

This study evaluated whether there is a relationship between the zona pellucida birefringence (ZP-BF) intensity and the nuclear (NM) and cytoplasmic (CM) in vitro maturation of human oocytes from stimulated cycles. When the oocyte is preparing for ovulation and interaction with spermatozoon, a series of changes occur inside of this cell. This is a complex process that includes nuclear, meiotic and cytoplasmic events [1]. To reach optimal competence for further development, cytoplasmic oocyte maturation (CM) must occur in synchronization to nuclear maturation (NM). The zona pellucida (ZP) is a unique extracellular coat that surrounds the maturing oocyte during ovulation, fertilization and early embryonic development [2]. According to Montag et al [5], a high/positively scoring ZP-BF probably reflects a healthy oocyte with full nuclear and cytoplasmic maturation

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call